Market Research Reports

Wednesday 30 September 2020

Drug Infusion System Market SWOT Analysis, Segmentation and Key Companies Profile Till 2023

Global Drug Infusion System Market Research Report, by Product Type (Elastomeric Infusion System, Disposable Infusion System), by Application (Oncology/Chemotherapy), Mode of Administration (Intravenous), End-User (Hospitals) - Global Forecast Till 2023

Segmentation

The global drug infusion system market is segmented on the basis of product type, mode of administration, application, and end-user. The drug infusion system market, is sub-segmented into Elastomeric infusion system, Disposable infusion system, Syringe infusion system, Peristaltic pump, Multi-channel pump, Patient-controlled analgesia (PCA) pump, Insulin pump and Implantable infusion system.

On the basis of Application, the market is categorized into Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, and others. Mode of administration is further sub-segmented into Intravenous, Subcutaneous, Arterial, Epidural and Others. By end-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic centers and others.

Key Players

Some of the key players for the global drug infusion system market are Medtronic, Arcomed AG, B. Braun Melsungen AG, Baxter, Becton Dickinson and Company, Debiotech S.A., Fresenius SE & Co. KGaA, Halyard Health, Inc, ICU Medical Inc, IRadimed Corporation, Insulet Corporation, Terumo Corporation, Smiths Group plc, Tandem Diabetes care, MOOG INC., and others.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/6207

Regional Analysis

The Americas dominated the global drug infusion system market in 2017. This can be attributed due to the rising incidence of chronic diseases like cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis within the region provides favorable backgrounds for market growth. According to the American Heart Association (2018), 92.1 million Americans suffer from some form of the cardiovascular disease. Also, the presence of major market players such as Medtronic and Becton, Dickinson and Company within the region influences the market growth.

Europe (the UK, Belgium, France & Netherlands) is second in the market owing to increasing healthcare expenditure, and rising prevalence of chronic respiratory diseases is expected to influence the market in this region. According to Eurostat in 2014, 382 thousand deaths were due to chronic respiratory diseases in the European Union (EU). Thus, the rise in chronic respiratory diseases favors the growth of the market in this region.

Asia Pacific is expected to observe the fastest growth for the global Drug infusion system market owing to a growing geriatric population in this region. The Asian Development Bank (ADB) projected that in 2050 the geriatric population is expected to reach 923 million. This offers potential growth opportunities in this region.

The Middle East and Africa accounts for least share due to stringent government policies and poor economies.

Market Highlights

The increase in the prevalence of chronic diseases such as cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis drives the market growth. Furthermore, adoption of technologically advanced devices and the rising geriatric population are the key factors for the market to grow. However, factors such as the high cost of drug infusion system, shortage of skilled labor and stringent government rules and regulations for product approval are expected to restrict the market growth during the forecast period.

Brows More Healthcare Related Research Reports:

UTI Treatment Market Size, Growth Analysis | Application, 2023

Electrotherapy Market Trends, Size Analysis | Share Value, 2023

Folliculitis Market Size, Growth Analysis | Industry Trends, 2023

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Nystagmus Market Insights, Share, Emerging Trends By 2023

Nystagmus Market Share And Application By Type (Infantile, Latent Nystagmus, Noonan Syndrome, Nystagmus Blockage Syndrome) Diagnosis (Ct Scan, Mr Scan, Chromosome Analysis, Ultrasonography) Treatment (Medication, Surgical) End-User – Global Forecast Till 2023

Segmentation:

The Nystagmus market is segmented on the basis of type, diagnosis, treatment, and end-users.

Based on the type, the market is segmented into infantile, latent nystagmus, noonan syndrome, and nystagmus blockage syndrome.

On the basis of the diagnosis, the market is segmented into CT scan, MR scan, chromosome analysis, ultrasonography, and others.

On the basis of the treatment, the market is segmented into medications, surgical, and others.

On the basis of the end-user, the market is segmented into hospitals & clinics, research centers, specialty eye clinics, and others.

Key Players:

Some of key the players in the global Nystagmus market are Bristol-Myers Squibb Company, NUSAPURE, ALLERGAN, Aerie Pharmaceuticals, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, Genentech, Inc., Novartis AG , Regeneron Pharmaceuticals, Inc., Shire, and Santen Pharmaceutical Co., Ltd., and others.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/5441

Market Overview:

Increasing prevalence of rare diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds are driving the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period, 2017-2023.

The global Nystagmus market is expected to grow at a CAGR of ~6.2 % during the forecast period 2017-2023. According to the Association for Research in Vision and Ophthalmology (2012), the prevalence of Nystagmus was estimated to be 24.0 per 10,000 population across the globe. The study identified the following as the most common forms of Nystagmus; neurologic Nystagmus (6.8 per 10,000 population), Nystagmus associated with low vision such as congenital cataracts (4.2 per 10,000), and Nystagmus associated with retinal diseases

Regional Analysis:

The Americas dominate the global Nystagmus market owing to the presence of a huge patient population with eye problem, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest share of the global Nystagmus market as result of increasing focus of various government agencies on the treatment of eye diseases. Moreover, the growing public awareness about Nystagmus is likely to boost the European market.

The Asia Pacific region is expected to be the fastest growing region and is anticipated to compete with the American and European region during the forecasted period 2017-2023. Japan holds the major share of the regional market due to the availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development is projected to drive the market in China and India over the forecasted period.

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The U.A.E., Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.

Brows More Healthcare Related Research Reports:

Diabetes Market Research Report Forecast To 2023 | MRFR

Pregnancy Test Kits Market Size, Trends Analysis | Growth, 2023

Pregnancy Pillow Market Size, Growth | Share Analysis, 2023

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Meralgia Paresthetica Market Profile, Key Players, Dynamics | Forecast to 2023

Meralgia Paresthetica Market Research Report: By Diagnosis (Imaging Techniques, Electromyography, Nerve Conduction Study, Nerve Blockade), Treatment (Medication, Surgery), End User (Hospitals & Clinics, Research Laboratories) - Global Forecast till 2023

Segmentation

The global meralgia paresthetica market is segmented on the basis of types, by treatment, and by end user. On the basis of diagnosis it is segmented into imaging techniques, electromyography, nerve conduction study, nerve blockade. Imaging techniques is further segmented into X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, and others. Based on the treatment, it is segmented into medication, surgery, and others. Medication is further segmented into corticosteroid injections, tricyclic antidepressants, and anti-seizure. Anti-seizure is further segmented into gabapentin (gralise, neurontin), phenytoin (dilantin) or pregabalin (lyrica) and others. On the basis of end user, it is segmented into hospitals & clinics, research laboratories, and others.

Key Players

Some of key the players in the meralgia paresthetica market are LivaNova PLC (U.K), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), NeuroMetrix, Inc.(U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc.(U.S.) and others.

Regional Analysis

The Americas dominate the global meralgia paresthetica market owing to the presence of huge patient population with obesity and diabetes, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest share of the global meralgia paresthetica market as result of increasing focus of various government agencies on the treatment of chronic diseases. Moreover, the growing public awareness about meralgia paresthetica likely to boost the European market.

Asia Pacific is the fastest growing meralgia paresthetica market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/5313

Market Overview

The global meralgia paresthetica market is expected to grow at a CAGR of ~7.9 % during the forecast period 2017-2023. According to Obesity Society, in the United States (2014), 28.1% of the total population was obese. Out of them, 33.7% were men and 36.5% were women. The prevalence of obesity for men and women aged 20-39 years was 39.5% and 35.4%, respectively. The obesity prevalence was higher in the South (29.4%) and Midwest (29.5%) and lower in the Northeast (25.3%) and West (25.1%) of Unites States.

During last decade the number of treatment procedures have increased which has influenced the growth of the market positively. Moreover, increasing number of patients suffering from chronic diseases have increased the demand different treatments in the market. The market is expecting a healthy growth during the next decade. Moreover, well developed technology has supported the growth of the market in this region.

Brows More Healthcare Related Research Reports:

Middle East and Africa Orthotic Devices Market Trends Analysis, Size | Share, 2023

Infrared Spectroscopy Devices Market Size, Trends | Growth Analysis, 2023

Asia-Pacific Glaucoma Treatment Market Trends, Size Analysis | Applications, 2023

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com .

Calciphylaxis Treatment Market Solutions, Services, Opportunities and Challenges Till 2023

Calciphylaxis Market Information: By Diagnosis (Deep Skin Biopsies, Blood Tests and Imaging), Treatment, (Intensive Wound Care, Medication, Therapy, and Clot-Dissolving), End User (Hospitals, Clinics, Medical Research Centers) - Global Forecast till 2023

Major Players in the Calciphylaxis Market

Some of the key players in this market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc, Sanifit, and others.

The Global Calciphylaxis Market is expected to grow at a CAGR of 10.70% during the forecast period 2017-2023. Warfarin is an oral anticoagulant which inhibits the synthesis of vitamin K- dependent clotting factors.

Segmentation

The global Calciphylaxis Market is segmented on the basis of diagnosis, treatment, and end user. On the basis of the diagnosis, the calciphylaxis market is further segmented into deep skin biopsies, blood tests, imaging, and others. The deep skin biopsies are further segmented into shave biopsy, punch biopsy, and excisional biopsy. The blood tests is further segmented into serum parathormone levels, blood glucose levels, BUN (blood urea nitrogen), calcium levels, and others. Imaging is further segmented into magnetic resonance imaging (MRI), CT scan, ultrasound, and others. On the basis of the applications, the market is segmented into intensive wound care, medication, therapy, clot-dissolving, and others. Intensive wound care unit is further segmented into debridement, wet dressings, and others. The medication is further segmented into cinacalcet, sodium thiosulfate, steroids, and bisphosphonates. On the basis of end user, it is segmented into hospitals, clinics, medical research centers, academic institutes, and others.

Market Highlights

These include bisphosphonates, newer non-calcium/non-aluminum-containing phosphate binders and case reports of use of cinacalcet. Other treatments for calcific uremic arteriolopathy (CUA) that are not targeted directly at calcium/phosphate homeostasis include HBOT and the sodium thiosulphate. The healthcare professionals have stated that randomized controlled trials for treatments in CUA are still lacking, which has restrained the growth of the market.

Warfarin is most commonly prescribed cardiovascular agent. However, excess use of anticoagulant increases the risk of calciphylaxis in treatment seeking population. According to the national pharmaceutical regulatory agency (2015), cases of calciphylaxis have been reported in patients on warfarin therapy. Although many of the cases reported for pre-existing renal disease.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/3567

A number options are available in the market for the treatment of calciphylaxis, which is associated with hypophosphatemia, and secondary hyperparathyroidism with chronic kidney disease. European Medicine Agency review concluded that there is reasonable possibility between calciphylaxis and use of warfarin. Taste the market data and market information presented through more than 144 market data tables and 34 figures spread over 152 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “calciphylaxis market research report–Global forecast till 2023.”

Regional Analysis

Asia Pacific consists of Japan, China, India, Australia, Republic of Korea, and rest of Asia Pacific. Increasing incidence of chronic kidney failure across Asia Pacific. Moreover, the growth of this segment is attributed to high population growth, increasing environmental pollution, and urbanization. Increasing incidence of calciphylaxis, improving healthcare infrastructure and rising awareness about the treatment process have spurred the growth of Asia Pacific region.

Europe consists of two regions namely Western Europe and Eastern Europe. Western Europe consists of countries namely Germany, the U.K., France, Italy, Spain, and Rest of Western Europe. Increasing prevalence of cardiovascular calcification in ESRD patients is a key driver for the growth of this market in Europe. Moreover, increasing healthcare expenditure, rising research & development activities, awareness among patients about the treatment options supporting the market growth for calciphylaxis.

The Americas account for a major share of the market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. Moreover, due to the high prevalence of end stage renal diseases (ESRD) on of the major cause of calciphylaxis in U.S. As per The Regents of the University of California, the rate of ESRD is increasing in the U.S. by 5% per year. The American calciphylaxis market is expected to reach USD 1,257 million by 2023 from USD 581.9 million in 2016.

On the other hand, the Middle East & Africa owns the minimum market share of the calciphylaxis market due to less development in the healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.

Brows More Healthcare Related Research Reports:

Artificial Retina Market Trends Analysis, Size | Applications, 2023

Africa Medical Devices Market Report - Forecast 2023 | MRFR

Cardiac surgery Instruments Market Size Analysis, Application | Industry Share, 2025

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 524/528, Amanora Chambers

Magarpatta Road, Hadapsar

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Eyelashes Enhancing Agents Market Growth, Size, Dynamics By 2023

Eyelashes Enhancing Agents Market

Eyelashes Enhancing Agents Market Application And Growth Analysis By Types, (Curling, Lengthening, Volumizing, And Others), Application (Repairing Damaged Eyelashes, Nourishing), Content (Bimatoprost, Lash-Building Serum, Skincare Ingredients) - Global Forecast Till 2023

Competitive Analysis:

Leading players in the global eyelashes enhancing agents market include Estee Lauder, Rodan & Fields LLC, Athena Cosmetics Inc., Beauty Essentials LLC, Grande Cosmetics LLC, Skin Research Laboratories, and Allergan plc.

In October 2018, Topix Pharmaceuticals launched Replenix PROLash, a new eyelash enhancing serum that uses the trademarked WideLash technology to strengthen and lengthen eyelashes.

Segmentation:

The global eyelashes enhancing agents market is segmented on the basis of types, application, and content.

On the basis of type, the eyelashes enhancing agents market is segmented into curling, lengthening, volumizing, and others. Curling is the fastest growing segment and is expected to exhibit a strong 6.15% CAGR over the forecast period.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/4862

On the basis of application, the eyelashes enhancing agents market is segmented into repairing damaged eyelashes, nourishing, and others. Repairing damaged eyelashes took up a majority share of 54% in the market in 2017 and is likely to remain in command over the forecast period.

On the basis of the content, the market is segmented into bimatoprost, lash-building serum, skincare ingredients, herbal remedy, isopropyl cloprostenate, enhancer serum, and others. The skincare ingredients segment is further sub-segmented into polypeptides, biotin, panthenol, and others.

Regional Analysis:

The global eyelashes enhancing agents market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas hold the dominant share in the global eyelashes enhancing agents market due to the widespread availability of advanced products in the region and the high disposable income of consumers in the region, which fuels a great desire to own the most advanced cosmetic products among female consumers. The Americas market is expected to rise to a valuation of USD 234.59 million by 2023.

On the other hand, Asia Pacific is likely to exhibit the fastest growth in the global eyelashes enhancing agents market over the forecast period. The Asia Pacific market is expected to grow at a CAGR of 6.26% over the forecast period due to the growing popularity of cosmetics products in the region’s developing economies.

Market Analysis

The global eyelashes enhancing agents market is expected to rise at a strong 5.83% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global eyelashes enhancing agents market is mainly driven by the growing prevalence of ocular conditions around the world, driven by the growing air pollution, among other factors. The growing attention paid by cosmetics manufacturers to the production of eyelashes enhancing agents is also likely to be a major driver for the market over the forecast period.

Eyelash enhancing serums are formulas that contain nutritive, strengthening, conditioning, and moisturizing components to deliver a comprehensive upgrade to the eyelashes. This important part of a person’s face has become all the more important with the rise of cosmetics. While eyelashes have always been a key part of a woman’s (and to a lesser extent, man’s) aesthetic getup, their conditioning and enhancement has now taken precedence thanks to the growing availability of a number of cosmetic products especially designed to enhance the eyelashes and add to their characteristics in a meaningful way.

The rising prevalence of diseases such as madarosis and blepharitis is likely to drive the eyelashes enhancing agents market over the forecast period. Cancer patients, especially breast cancer patients, often suffer from madarosis as a result of intensive radiotherapy procedures. As a result, the growing prevalence of cancer could also act as a key driver for the global eyelashes enhancing agents market over the forecast period.

A growth in the demand for natural ingredients in eyelashes enhancing formulations could emerge as a key determinant for the global eyelashes enhancing agents market over the forecast period. The demand for natural ingredients has been a feature of the overall medical sector in the last few years and could end up as an important factor for the eyelashes enhancing agents market over the forecast period as well.

Brows More Healthcare Related Research Reports:

Cervical Dystonia Market Trends Analysis, Share | Size, Forecast To 2023

Middle East and Africa Clinical Trial Imaging Market-Forecast to 2022 | MRFR

Saudi Arabia Medical Devices Market Report – Forecast 2023 | MRFR

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Perfusion Market Analysis, Development Trend and Investment Feasibility To 2023

Perfusion Market Information, By Type (Cardiopulmonary Bypass, Isolated Limb Perfusion, & Others), By Application (Heart, Lung, & Others), By Device Type (Normothermic Machine Perfusion, & Others), By End User (Hospital, & Others) - Global Forecast Till 2023

Global Perfusion Market - Segments

The perfusion market analysis is segmented into five key dynamics for enhanced understanding.

By Type : Cardiopulmonary Bypass, Extracorporeal Membrane Oxygenation, and Isolated Limb Perfusion among others.

By Application : Lungs, Heart, Liver, and Kidneys among others.

By Device Type : Hypothermic Machine Perfusion and Normothermic Machine Perfusion among others.

By End User : Hospital, Specialty Clinics, Medical Research Centers, and Academic Institutes among others.

By Regions : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/888

Global Perfusion Market - Regional Analysis

North American region heading with the increasing number of organ transplant surgeries dominates the global perfusion market, accounting for the largest share. Moreover, factors such as technological advancement and high per capita healthcare expenditures are expected to spur the market growth in the region.

The U.S. and Canada led by the rising number of chronic diseases associated with lungs, heart, liver, and kidneys lead the perfusion market in North America. Furthermore, the growing number of heart and kidney bypass surgeries and the growing prevalence of coronary diseases alongside the rapid uptake of advanced technologies and devices in the surgical process drive the growth in the regional market.

The perfusion market in the European region accounts for the second-largest market, globally. The region witnesses the increasing number of kidney & heart bypass procedures. Factors such as the availability of specialty care services in hospitals & tertiary care centers alongside the rising prevalence of cardiovascular diseases and the increasing demand for the treatment options of cardiovascular diseases escalate the market growth in the region.

Furthermore, the increasing healthcare expenditures led by the resurging economy in the region and spreading awareness towards bypass procedures impact the market growth in the region, positively.

The Asia Pacific perfusion market is emerging as a profitable market, worldwide. Factors such as the proliferating healthcare sector along with the flourishing medical tourism market in highly populated countries like India and China drive the regional market. Also, the rising cases of patients suffering from coronary diseases, increasing geriatric populace and spreading awareness about healthcare foster the growth of the regional market.

Overview

The perfusion market is growing pervasively mainly attributing to the increasing prevalence of chronic diseases associated with lungs, heart, liver, and kidneys which are the result of changing lifestyle. Over the last three decades, perfusions have evolved hugely, demonstrating remarkable advances which are leading to driving the growth of the market. Simultaneously, there has been a remarkable growth in the awareness about related surgeries required to managing these diseases which, as a result, are escalating the market on the global platform.

According to an eminent research firm, Market Research Future (MRFR) the perfusion market is growing steadily, globally, and is expected to continue growing in the years to come. In its recently published study report MRFR asserts that the global perfusion market will garner a valuation of USD 1,527 MN by 2023 posting approximately 4.1% CAGR throughout the assessment period (2017-2023).

Additionally factors such as the increasing population and urbanization led by the improving economic conditions that are increasingly expanding the access to the quality healthcare expanding the market size of profusion. Moreover, rising cases of lifestyle diseases, smoking, and consumption of alcohol which eventually lead to increasing the cases of organ failure are boosting the growth of the market.

On the other hand, factors such as the lack of awareness regarding perfusion systems in developing countries are impeding market growth.

Global Perfusion Market - Competitive Analysis

Highly competitive, the Perfusion market appears fragmented owing to the presence of several well-established market players. These players through strategic initiatives such as acquisition, partnership, expansion, product & technology launch, and collaboration, try to gain a competitive advantage and maintain their positions in the market. Huge investments are being transpired in the R&D to bring betterments in surgical procedures and to develop devices that are on a different level entirely compared to their competition.

Major Players

Medtronic (Ireland), Getinge AB (Sweden), LivaNova PLC (U.K.), XENIOS AG (Germany), Terumo Medical Corporation (Japan), Lifeline Scientific, Inc. (U.S.), Repligen Corporation (U.S.), XVIVO Perfusion (Sweden), Spectrum Laboratories, Inc. (U.S.), Harvard Bioscience, Inc. (U.S.), Merck KGaA (Germany), and Ala Science (U.S.) among others.

Industry/Innovation/Related News:

Circle Cardiovascular Imaging Inc. (Canada), leading global company developing analytical software for the cardiac imaging community announced the acquisition of Corstem Inc.(Canada), machine learning and artificial intelligence software developer specialized in cardiac imaging analysis to introduce automatic, fully-quantitative myocardial perfusion in cvi42.

The acquisition will further expand Circle’s innovative technology and product offerings with Corstem’s technologies integrated into Circle’s core product – cvi42, including an automatic and comprehensive solution for fully-quantitative myocardial perfusion.

Brows More Healthcare Related Research Reports:

Nanobots Market Size, Trends | Insights and Share Analysis, 2023

Neuromodulation Devices Market Trends, Share | Size Analysis, 2023

Cardiopulmonary Resuscitation Market Trends, Size | Share Analysis, 2023

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Clinical Intelligence Market Analysis, Growth Impact and Demand By Regions | Forecast to 2023

Clinical Intelligence Market Information: By Type (CDSS, Quality Improvement), Component (Service, Software), Application (Clinical, RCM), End User (Hospitals, Clinics, Tpas) - Global Forecast Till 2023

Regional Analysis

By region, the global clinical intelligence market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas account for the maximum share of the global clinical intelligence market owing to high usage of software solutions for healthcare administration. The presence of healthcare IT companies in the region and high healthcare expenditure supports market growth in the region. Additionally, growing usage of Decision Support System among tertiary care centers in the US has proven to be beneficial for the growth of the market.

Europe follows the Americas closely and is the second largest market for clinical intelligence. Increase in a number of healthcare institutions who are leveraging clinical intelligence management softwares and expanding healthcare expenditure boosts the market growth in Europe.

APAC is poised to be the fastest growing market for clinical intelligence. Development of healthcare IT infrastructure, increasing healthcare expenditure and the growing presence of key players in the region can be credited for the growth of the market. Besides, the growing burden of diseases and government initiatives towards the modernization of the healthcare system are also factors favoring market growth in APAC.

The MEA market is expected to showcase moderate growth. The Africa region, in particular, will exhibit limited growth due to low healthcare penetration and low healthcare expenditure.

Nuance Communications, US-based multinational computer software technology corporation, introduced its new clinical intelligence solution dubbed Ambient Clinical Intelligence at the 2019 Healthcare Information and Management Systems Society (HIMSS). The new solution is built on speech recognition technology of its Dragon Medical One cloud platform and would facilitate hands-free clinical documentation.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/4478

Market Trends and Insights

Clinical intelligence is a new learning paradigm for healthcare providers in which clinical data is analyzed with the use of modern data mining, data visualization, and predictive modeling tools to improve healthcare delivery. The usage of clinical intelligence is becoming a common phenomenon in healthcare institutes worldwide and the global clinical intelligence market is poised to strike a splendid CAGR of 12.5% over the forecast period of 2017-2023, predicts Market Research Future (MRFR) in an exhaustive study.

The pressing need to curb healthcare costs has been the primary drive motivating the growth of the global clinical intelligence market. The growing burden of chronic diseases and increasing patient influx in hospitals has raised the adoption of software solutions for tedious process such as insurance claim processing and fraud detection. This results in improved healthcare outcomes and subsequently boosts the growth of the market.

Growing interest by the healthcare sector towards making data-driven decisions and growing integration of Big Data analytics is also acting as a plus for the market growth. Moreover, growing demand for precision and personalized medicine has spurred the adoption of clinical intelligence on a global scale.

Other factors stimulating the market growth include governments in multiple countries encouraging the adoption of clinical intelligence solutions. Furthermore, constant changes in regulations, increasing reporting mandates, and ever-increasing competition, healthcare organizations can no longer ignore the importance of clinical intelligence. Clinical intelligence aids healthcare sector to improve the quality of care by analyzing the gaps in their care, patient safety, efficiency, and cost-effectiveness.

On the other hand, a general lack of regulatory and clinical standards for predictive analytics is likely to hinder the growth of the market. The high cost of clinical intelligence software might restrain the growth of the market growth in developing countries.

Competitive Landscape

The notable players in the clinical intelligence market include General Electric Company (U.S.), QSI Management, LLC (U.S.), Allscripts (U.S.), Cerner Corporation (U.S.), IBM (U.S.), Epic Systems Corporation (U.S.), Greenway Health, LLC (U.S.), McKesson Corporation (U.S.), and eClinicalWorks (U.S.).

Segmentation

The global clinical intelligence market has been segmented based on component, type, end-user, and application.

By type, the global clinical intelligence market has been segmented into population health management, retrospective performance measures & predictive analytics, clinical benchmarking, clinical decision support (CDSS) system, quality improvement, performance measurement systems, and others. The quality improvement segment has been further segmented into six sigma. The population health management segment has been further segmented into under-utilization of health services and over-utilization of health services.

By component, the global clinical intelligence market has been segmented into hardware, software, and services.

By application, the global clinical intelligence market has been segmented into revenue cycle management (RCM) claims, fraud, supply chain, financial management, clinical, and others.

By end-users, the global clinical intelligence market has been segmented into clinics, hospitals, TPAs, and others.

Brows More Healthcare Related Research Reports

Artificial Insemination Market Size Analysis, Share | Industry Trends, 2025

Global Suture wire Market Research Report - Forecast to 2023 | MRFR

Neuropsychiatric Disorders and Treatment Market size, Insights | Industry Trends, 2023

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com